Disclosure of shareholdings – Holta Invest AS (2025)

03. Mar 2025 | 1 min read

3 March 2025

Holta Invest AS has today sold 1,228,502 shares in Gentian Diagnostics ASA and holds after this transaction no longer any shares in Gentian Diagnostics ASA.

Consequently, Holta Invest AS has passed the 5% threshold pursuant to Section 4-2 (1) of the Norwegian Securities Trading Act.

This information is subject to the disclosure requirements pursuant to Section 4-2 and 5-12 of the Norwegian Securities Trading Act

You may also read


Jul 02, 2026 - Ole Sørlie

Gentian Diagnostics: Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

Jun 24, 2026 - Ole Sørlie

ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

May 29, 2026 - Ole Sørlie

Mandatory notification of trade

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..